STAT News · Scour

STAT+: The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades

statnews.com·3w

How Trump is pushing psychedelics reform through the health agencies

statnews.com·3w

Opinion: The podcast bringing together MAHA and public health for hard conversations

statnews.com·3w

Optimism for Trump’s CDC pick is tempered by questions about RFK Jr.’s role

statnews.com·3w

STAT+: A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment

statnews.com·3w

STAT+: FDA eyes expanding testosterone therapy for libido

statnews.com·3w

The deadly consequences of ICE detention

statnews.com·3w

STAT+: Up and down the ladder: The latest comings and goings

statnews.com·3w

STAT+: Pharmalittle: We’re reading about Lilly weight loss pill trial results, slashed U.K. clinical trial times, and more

statnews.com·3w

STAT+: Cell therapy primed liver transplant patients to avoid organ rejection, small study shows

statnews.com·3w

Opinion: Don’t believe headlines saying that vaccine skepticism is widespread

statnews.com·3w

Opinion: Health care is not ready for the new era of AI-enabled cyberattacks

statnews.com·3w

STAT+: HaloMD’s legal win highlights the difficulty of challenging arbitration decisions

statnews.com·4w

Trump taps former public health leader Erica Schwartz to run CDC

statnews.com·4w

A pancreatic cancer breakthrough, and new hope for an off-the-shelf CAR-T treatment

statnews.com·4w

STAT+: Kennedy focuses on affordability, combating fraud in Capitol Hill hearing

statnews.com·4w

STAT+: Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target

statnews.com·4w

STAT+: Cochrane review reignites Alzheimer’s amyloid wars

statnews.com·4w

STAT+: RFK Jr. begins his testimony marathon

statnews.com·4w

STAT+: Pharmalittle: We’re reading about a review of Alzheimer’s drugs, FDA interest in compounded peptides, and more

statnews.com·4w

Log in to enable infinite scrolling